MyFinsight
Home
Blog
About
Back
Income Statement
NextCure, Inc. (NXTC)
NextCure, Inc. (NXTC)
source: myfinsight.com
Total comprehensive
loss
-$14,893K
(44.46%↑ Y/Y)
Net loss
-$14,892K
(44.45%↑ Y/Y)
Unrealized gain on
marketable securities
-$1K
(85.71%↑ Y/Y)
Other income, net
$202K
(-58.26%↓ Y/Y)
Loss from operations
-$15,094K
(44.69%↑ Y/Y)
Total operating
expenses
$15,094K
(-44.69%↓ Y/Y)
Research and development
$7,425K
(-69.18%↓ Y/Y)
Restructuring and asset
impairment charges
$5,077K
General and
administrative
$2,592K
(-19.03%↓ Y/Y)
Back